(NP (NP Mineralocorticoid/NN effector/NN mechanism/NN) (PP in/IN (NP preeclampsia/NN)) ./.)
(S (NP-SBJ-36 Mineralocorticoid/NN effector/NN mechanisms/NNS) (VP were/VBD (VP evaluated/VBN (NP *-36/-NONE-) (PP-COOD (PP in/IN (NP (NP 29/CD patients/NNS) (PP with/IN (NP preeclampsia/NN)))) and/CC (PP in/IN (NP 25/CD uncomplicated/JJ pregnancies/NNS))) (PP by/IN (NP (NP measurement/NN) (PP of/IN (NP-COOD (NP plasma/NN aldosterone/NN) ,/, (NP (NP levels/NNS) (PP of/IN (NP (NP (NP mineralocorticoid/NN receptor/NN) (PRN -LRB-/-LRB- (NP MR/NN) -RRB-/-RRB-)) (PP in/IN (NP mononuclear/JJ leucocytes/NNS))))) ,/, and/CC (NP (NP subtraction/NN potential/NN difference/NN) (PRN -LRB-/-LRB- (NP SPD/NN) ;/: (NP (ADJP-COOD (ADJP rectal/JJ) minus/CC (ADJP oral/JJ)) values/NNS) -RRB-/-RRB-)))))))) ./.)
(S-COOD (S (NP-SBJ (NP Mean/NN values/NNS) (PP for/IN (NP plasma/NN aldosterone/NN))) (VP were/VBD not/RB (ADJP-PRD different/JJ) (PP between/IN (NP the/DT two/CD groups/NNS)))) ,/, but/CC (S (NP-SBJ-37 significant/JJ differences/NNS) (VP were/VBD (VP observed/VBN (NP *-37/-NONE-) (PP for/IN (NP-COOD (NP (NP MR/NN) (PRN -LRB-/-LRB- (NP-COOD (NP (NP preeclampsia/NN) ,/, (NP (QP 81/CD +\/-/CC 44/CD) receptors\/cell/NNS)) ;/: (NP (NP controls/NNS) ,/, (NP (QP 306/CD +\/-/CC 168/CD)))) -RRB-/-RRB-)) and/CC (NP SPD/NN (PRN -LRB-/-LRB- (NP-COOD (NP (NP preeclampsia/NN) ,/, (NP (QP 65/CD +\/-/CC 7/CD) mV/NN)) ;/: (NP (NP controls/NNS) ,/, (NP (QP 12/CD +\/-/CC 5/CD) mV/NN))) -RRB-/-RRB-))))))) ./.)
(S (PP In/IN (NP six/CD cases/NNS)) (NP-SBJ we/PRP) (VP determined/VBD (NP (NP-COOD (NP MR/NN) ,/, (NP plasma/NN aldosterone/NN) ,/, and/CC (NP SPD/NN)) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP preeclampsia/NN)) (PP-TMP (PP-COOD (PP before/IN (NP *RNR*-38/-NONE-)) and/CC (PP (NP 3/CD months/NNS) after/IN (NP *RNR*-38/-NONE-))) (NP-38 delivery/NN)))))) ./.)
(S (S-COOD (S (NP-SBJ-39 MR/NNS) (VP were/VBD (VP (VP reduced/VBN (NP *-39/-NONE-) (PP-TMP before/IN (NP delivery/NN))) (PRN -LRB-/-LRB- (NP (QP 96/CD +\/-/CC 27/CD) receptors\/cell/NNS) -RRB-/-RRB-)))) ,/, and/CC (S (NP-SBJ SPD/NN) (VP (VP increased/VBD) (PRN -LRB-/-LRB- (NP (QP 64/CD +\/-/CC 8/CD) mV/NN) -RRB-/-RRB-)))) ,/, (PP with/IN (S (NP-SBJ both/DT parameters/NNS) (VP (VP normalizing/VBG (PP-TMP after/IN (NP delivery/NN))) (PRN -LRB-/-LRB- (NP-COOD (NP (NP MR/NN) ,/, (NP (QP 242/CD +\/-/CC 79/CD))) ;/: (NP (NP SPD/NN) ,/, (NP (QP 14.0/CD +\/-/CC 4/CD) mV/NN))) -RRB-/-RRB-)))) ./.)
(S (NP-SBJ Aldosterone/NN levels/NNS) (VP returned/VBD (PP to/TO (NP normal/JJ nonpregnant/JJ values/NNS)) (PP-TMP after/IN (NP delivery/NN))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP-COOD (VP suggest/VBP (NP (NP an/DT important/JJ role/NN) (PP for/IN (NP (NP abnormalities/NNS) (PP in/IN (NP mineralocorticoid/NN effector/NN mechanisms/NNS)))) (PP in/IN (NP (NP the/DT etiology/NN) (PP of/IN (NP preeclampsia/NN)))))) and/CC (VP could/MD (VP be/VB (NP-PRD (NP an/DT useful/JJ marker/NN) (PP for/IN (NP diagnosis/NN)))))) ./.)
